MAGNETOM Vida with syngo MR XA50A

The MAGNETOM Vida with syngo MR XA50A is a magnetic resonance diagnostic device designed to produce detailed anatomical and functional images and spectra for diagnostic and interventional purposes. This updated system primarily introduces advanced software functionalities, leveraging deep learning for image reconstruction and specialized pulse sequences to enhance image quality, reduce scan times, and improve workflow for various clinical applications, including brain imaging, diffusion-weighted imaging, and angiography.

The MAGNETOM Vida with syngo MR XA50A is a magnetic resonance diagnostic device (MRDD) intended for generating a comprehensive range of images and spectra, including transverse, sagittal, coronal, and oblique cross-sectional views, as well as spectroscopic data. It visualizes the internal structure and function of the head, body, or extremities, with the option of using contrast agents depending on the region of interest. The information derived from these images and spectra, when interpreted by trained physicians, aids in diagnosis and can also be utilized for guiding interventional procedures performed with MR-compatible devices. This system iteration introduces significant software enhancements over its predecessor, primarily through the syngo MR XA50A software package. Key new features include 'Deep Resolve Swift Brain' for rapid brain imaging using echo planar imaging and deep learning reconstruction, 'Deep Resolve Boost' for deep learning-based reconstruction of 2D TSE data, 'BLADE diffusion' and 'HASTE diffusion' for improved diffusion-weighted imaging with reduced artifact sensitivity. Modified features aim to further refine image quality and workflow, such as 'Fast GRE RefScan' for quicker calibrations, 'Static Field Correction' for distortion reduction, 'Deep Resolve Gain' and 'Deep Resolve Sharp' for enhanced SNR and image sharpness (now extended to SE and TSE_DIXON sequences), 'myExam Angio Advanced Assist' for streamlined peripheral angiography, 'TSE MoCo' for motion correction in TSE sequences, and improved 'MR Breast Biopsy' with automatic fiducial detection.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the 'Deep Resolve Swift Brain' protocol quantitatively compare in diagnostic accuracy and scan time reduction to standard brain MRI protocols without deep learning assistance for various neurological conditions?; What are the specific improvements in image quality (e.g., SNR, CNR, spatial resolution, artifact reduction) achieved by 'Deep Resolve Boost' for 2D TSE data across different anatomical regions and patient populations?; Can the 'BLADE diffusion' and 'HASTE diffusion' techniques demonstrate superior image quality and diagnostic utility in challenging areas prone to B0 inhomogeneity artifacts (e.g., near sinuses, skull base, or metallic implants) compared to conventional EPI-DWI?; What is the learning curve and workflow integration efficiency for clinicians using the 'myExam Angio Advanced Assist' for peripheral angiography, and how does it impact overall procedure time and contrast media usage?; How robust is the 'TSE MoCo' image-based motion correction for various types and magnitudes of patient motion, and does it introduce any new artifacts or compromise diagnostic information in specific TSE sequences?